The pharmacokinetics and pharmaco-dynamics of Procysteine in amyotrophic lateral sclerosis.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 10227642.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In 13 subjects with ALS, we studied the safety and pharmacokinetic properties of Procysteine, a cysteine prodrug that increases levels of intracellular glutathione. We found that oral administration of Procysteine was safe. Procysteine enters CSF after both IV and oral dosing and accumulates to significant levels in CSF. We also observed that CSF levels of glutathione fall dramatically with aging.
Medical subject headings
- Amyotrophic Lateral Sclerosis
- Thiazoles